Jay David Caplan net worth and biography

Jay Caplan Biography and Net Worth

https://www.linkedin.com/in/ian-sheffield-b2021a/ of Fractyl Health

Jay Caplan is Co-Founder, President, and Chief Product Officer of Fractyl Health and has held leadership positions in the medical device field for more than 20 years.

Prior to founding Fractyl Health, Jay was the Chief Operating Officer of the Candela Corporation, a world leader in aesthetic devices. Previously, he was Chief Technology Officer and Vice President of Research and Development at InfraReDx, Inc. a venture-backed startup developing a novel cardiovascular imaging system to identify lipid-rich coronary plaques.

Prior to InfraReDx, Jay was Vice President of Operations for Thermo Cardiosystems, where he led the team developing the HeartMate II left ventricular assist device. Jay holds a B.S. in electrical engineering from M.I.T. and an MBA from The Wharton School of the University of Pennsylvania.

What is Jay David Caplan's net worth?: The estimated net worth of Jay David Caplan is at least $113.90 thousand as of January 31st, 2025. Mr. Caplan owns 153,544 shares of Fractyl Health stock worth more than $113,899 as of August 28th. This net worth evaluation does not reflect any other assets that Mr. Caplan may own. Learn More about Jay David Caplan's net worth.
How do I contact Jay David Caplan?: The corporate mailing address for Mr. Caplan and other Fractyl Health executives is 17 Hartwell Avenue, Lexington, MA 02421, United States. Fractyl Health can also be reached via phone at 781-902-8800 and via email at [email protected]. Learn More on Jay David Caplan's contact information.
Has Jay David Caplan been buying or selling shares of Fractyl Health?: Jay David Caplan has not been actively trading shares of Fractyl Health during the last quarter. Most recently, Jay David Caplan sold 22,346 shares of the business's stock in a transaction on Friday, January 31st. The shares were sold at an average price of $1.81, for a transaction totalling $40,446.26. Following the completion of the sale, the insider now directly owns 153,544 shares of the company's stock, valued at $277,914.64. Learn More on Jay David Caplan's trading history.
Who are Fractyl Health's active insiders?: Fractyl Health's insider roster includes Jay Caplan (https://www.linkedin.com/in/ian-sheffield-b2021a/), Harith Rajagopalan (CEO), Ajay Royan (Director), and Ian Sheffield (Director). Learn More on Fractyl Health's active insiders.
Are insiders buying or selling shares of Fractyl Health?: During the last twelve months, Fractyl Health insiders bought shares 6 times. They purchased a total of 181,909 shares worth more than $147,148.61. The most recent insider tranaction occured on June, 12th when Director Ajay Royan bought 23,000 shares worth more than $19,550.00. Insiders at Fractyl Health own 8.5% of the company. Learn More about insider trades at Fractyl Health.
Information on this page was last updated on 6/12/2026.

Jay David Caplan Insider Trading History at Fractyl Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/31/2025	Sell	22,346	$1.81	$40,446.26	153,544
11/11/2024	Sell	64,197	$2.47	$158,566.59	153,544
9/12/2024	Sell	65,000	$2.90	$188,500.00	30,484

Jay David Caplan Buying and Selling Activity at Fractyl Health

Fractyl Health Company Overview

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $0.74

$0.74

$0.76

50 Day Range

MA: $0.75

$0.66

$0.91

2 Week Range

Now: $0.74

$0.38

$2.45

Volume

56,479 shs

Average Volume

3,196,592 shs

Market Capitalization

$117.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32